These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27634346)

  • 81. Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.
    Gan XN; Gan TQ; He RQ; Luo J; Tang RX; Wang HL; Zhou H; Qing H; Ma J; Hu XH; Chen G
    Oncol Lett; 2018 May; 15(5):6418-6430. PubMed ID: 29616113
    [TBL] [Abstract][Full Text] [Related]  

  • 82. microRNAs Make the Call in Cancer Personalized Medicine.
    Detassis S; Grasso M; Del Vescovo V; Denti MA
    Front Cell Dev Biol; 2017; 5():86. PubMed ID: 29018797
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study.
    Wang X; Zhang Y; Zhi X
    Thorac Cancer; 2017 Sep; 8(5):511-516. PubMed ID: 28727276
    [TBL] [Abstract][Full Text] [Related]  

  • 84. MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.
    Bai M; Zhang M; Long F; Yu N; Zeng A; Wang X
    Am J Transl Res; 2017; 9(2):647-655. PubMed ID: 28337292
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 87. MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.
    Cai Y; Ruan J; Yao X; Zhao L; Wang B
    Oncol Rep; 2017 May; 37(5):2787-2794. PubMed ID: 28393200
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 89. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

  • 90. MicroRNA‑187 is an independent prognostic factor in lung cancer and promotes lung cancer cell invasion via targeting of PTRF.
    Peng J; Liu HZ; Zhong J; Deng ZF; Tie CR; Rao Q; Xu W; You T; Li J; Cai CB; Lu Q; Liu W; Zhang Y; Lei ZY
    Oncol Rep; 2016 Nov; 36(5):2609-2618. PubMed ID: 27634346
    [TBL] [Abstract][Full Text] [Related]  

  • 91. NOB1: A Potential Biomarker or Target in Cancer.
    Ke W; Lu Z; Zhao X
    Curr Drug Targets; 2019; 20(10):1081-1089. PubMed ID: 30854959
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.